ArticleMolecular cancer therapeutics2023

Identification of a First-in-Class Small-Molecule Inhibitor of the EIF4E-RBM38 Complex That Enhances Wild-type TP53 Protein Translation for Tumor Growth Suppression.

Christopher A Lucchesi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.